About: Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1997 (uk) article scientifique publié en 1997 (fr) im November 1997 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1997 (en) artículu científicu espublizáu en payares de 1997 (ast)
publication date	wds:Q73875926-CA1B48F6-AD86-46A4-962E-56D064595C3A
publication date	1997-11-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73875926-0BCB94AD-78F1-40A1-B028-EA335DA4464F wds:Q73875926-0ED882A6-FC6C-4CE8-B93A-16F4BB59A479 wds:Q73875926-162F85AE-AE8A-4329-8E78-D09E534C9B7B wds:Q73875926-1FC38831-49D8-4C19-B12D-5B95B3BE9EC2 wds:Q73875926-35F23791-9F39-4A4C-9DC5-0CE6A54999A8 wds:Q73875926-38E4E7A0-EB77-4998-9A32-B529A0D2A597 wds:Q73875926-506207EA-EAF2-47E9-8628-28D8F2F8A4C1 wds:Q73875926-5D4F1C7E-C168-4568-AF7B-BC1AA9B3CFBE wds:Q73875926-642D1B68-762F-4306-9AE2-F6DCB1233C4F wds:Q73875926-6593F5D4-F566-4DF8-BEA4-5677C6CEE4AA wds:Q73875926-7586BB70-A69C-4CDE-BE3B-A571FFBF66B8 wds:Q73875926-7EA9280B-0653-4072-96D9-A9006E8C3AA7 wds:Q73875926-AC382677-5E08-43A5-AA93-8BCCA3687FA9 wds:Q73875926-CDB9B8B4-73C8-4DC6-9B71-C8F804313922 wds:Q73875926-D081F0D3-22AC-42A7-A61A-90007E38B112 wds:Q73875926-D58ED91D-0B88-43C2-A66E-FB2599E53DEE wds:Q73875926-D95F3E90-FA9D-475C-97D1-1834708A2D83 wds:Q73875926-DA2E1CB5-3EDB-43D4-9BC4-4A10983CAD9E wds:Q73875926-EDED956C-320B-40C5-BFFD-14F7E288CBE9 wds:Q73875926-F8F38D52-CF94-495E-8B02-68AABFC9FC5E wds:Q73875926-FA74DB46-03B3-411E-BCE4-B6C1A13D355F wds:Q73875926-FC2349D4-4EF4-4309-B185-BE90F7F41FDB
cites work	Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Silica-induced scleroderma Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Polyclonal human T-cell activation by silicate in vitro Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations Leukocyte immunophenotypes in bronchoalveolar lavage fluid and peripheral blood of paracoccidioidomycosis, sarcoidosis and silicosis Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B Immunotoxicology of silica The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly. Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
author name string	wds:Q73875926-19BABC0B-8E6E-4FCC-A647-276670452D31 wds:Q73875926-2E57C0A6-C124-4ACE-833A-B9947C22F989 wds:Q73875926-3261F9B9-38AA-4A0A-810D-88249ED197CA wds:Q73875926-62A4442A-2696-47F2-A01A-2ADA48707E27 wds:Q73875926-6530EE40-1664-4FE3-A524-D32947A10511 wds:Q73875926-BA195E16-AF97-419F-B222-6AE0A472E5C4 wds:Q73875926-D1A4BDDB-F57E-487E-BE35-3C2F316FC6C0 wds:Q73875926-D8CEFAA6-584F-4632-97F2-449275F76392 wds:Q73875926-DF625D03-E2FA-4816-BD08-F9D1868B6961 wds:Q73875926-F39735CF-54F0-4437-B674-309E822F61FB
author name string	T Kishimoto M Kusaka T Otsuki H Ueki T Matsuki A Ueki S Kita T Aikoh A Tomokuni Y Isozaki
rdfs:label	Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours (en) Elevated soluble Fas/APO-1 (nl)
skos:prefLabel	Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours (en) Elevated soluble Fas/APO-1 (nl)
name	Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours (en) Elevated soluble Fas/APO-1 (nl)
title	wds:Q73875926-5355C440-64FD-4584-A4E6-52BBE7098098
title	Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours (en)
page(s)	wds:Q73875926-AB51DA05-7C97-4107-881A-851E4672FF05
page(s)	303-309
instance of	wds:Q73875926-102B5B0D-219F-4B81-9868-33F3C1C550BB
instance of	scholarly article
PubMed ID	wds:Q73875926-F50995B5-7C20-4F5A-B25D-692DA9F3641E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9367417
PubMed ID	9367417
published in	wds:Q73875926-78630FDE-96D5-4397-B303-4345C9AC3D04
published in	Clinical and Experimental Immunology
issue	wds:Q73875926-4A1FDE40-4C4B-476D-B99A-9ECA3A39DF8E
volume	wds:Q73875926-05971040-5ED6-4173-A2AB-2F797EDF1D5F
issue	2
volume	110
DOI	wds:Q73875926-52C02C73-91CA-4AB3-8AE6-994579070969
DOI	http://dx.doi.org/10.1111/J.1365-2249.1997.TB08332.X
DOI	10.1111/J.1365-2249.1997.TB08332.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73875926
is cites work of	Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients Serum levels of soluble Fas ligand in patients with silicosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software